Corneat Vision has the goal of restoring eyesight for blinds. The Company will begin its process in china after the funding round ended with another 4 million dollars from Guangzhou Sino-Israel Biotech Investment Fund.  

The company, now an Israeli - Chinese collaboration, will base in china clinical trials, production lines, and selling products to the local market.